NEOGENOMICS, INC.
FT MYERS, FLORIDA

NeoGenomics, Inc., founded on March 3, 2009, is a leading company in molecular genetics testing based in Florida. With its headquarters at 9490 NeoGenomics Way, Fort Myers, they focus on offering advanced diagnostic solutions to healthcare sectors like oncology, infectious diseases, genetic disorders, cardiology, and neuroscience, among others. As a for-profit corporation, NeoGenomics is recognized as a domestic company with roots outside of Florida but maintains significant operations within the state. Recent reports highlight the company's solid growth and ongoing innovation in the field of genetic and molecular testing services. Key figures at NeoGenomics include Directors Stephen Kanovsky and Michael A. Kelly. The organization extends its reach through comprehensive service offerings from its Fort Myers headquarters, backed by an extensive network for laboratory testing capabilities. Their mission is centered on enhancing patient care globally with high-quality and prompt diagnostic tests that aid healthcare providers in making well-informed clinical decisions quickly. Emphasizing innovation and adherence to high quality standards, NeoGenomics also holds a Federal Employer Identification Number (FEI) of 74-2897368. Those interested can learn more about their services by visiting their website at neogenomics.com.